Nifty Pharma Index Drops on Aurobindo Pharma's Performance

The Nifty Pharma index witnessed a decline, with Aurobindo Pharma dragging sentiment due to weak earnings and regulatory concerns. The sector, which was previously resilient, is now facing pricing pressures and global headwinds, leading to a cautious outlook. 💊 Follow Bull & Bear School and Finance Lens on Instagram for expert market updates!